Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) EBIT Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) EBIT Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 3.16%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 28.02%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 11.63%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 19.80%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 31.84%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 24.88%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -65.59%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 35.44%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 13.06%
10 Catheter Precision 553,488.01 -1.71 Mn 98,000.00 14.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.41%
Mar 31, 2026 67.33%
Dec 31, 2025 -6.28%
Sep 30, 2025 14.20%
Jun 30, 2025 17.87%
Mar 31, 2025 13.39%
Dec 31, 2024 28.26%
Sep 30, 2024 27.15%
Jun 30, 2024 27.88%
Mar 31, 2024 27.52%
Dec 31, 2023 36.67%
Sep 30, 2023 28.62%
Jun 30, 2023 14.57%
Mar 31, 2023 -104.36%
Dec 31, 2022 5.84%
Sep 30, 2022 35.21%
Jun 30, 2022 18.01%
Mar 31, 2022 28.34%
Dec 31, 2021 18.51%
Sep 30, 2021 -15.44%